Nursing care
Clozapine: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Clozapine is an atypical antipsychotic reserved for treatment-resistant schizophrenia because of agranulocytosis risk. An absolute neutrophil count is required before every dispense under REMS monitoring, and any fever or sore throat is treated as a stop-the-drug and check-the-count situation, not a wait-and-see one.
Why this drug and not another
Clozapine is not a first-line antipsychotic. It is reserved for schizophrenia that has failed to respond to at least two other antipsychotics, and for reducing suicidal behaviour in schizophrenia and schizoaffective disorder, because its risk profile does not justify use where another drug would work.
The reason it works when others fail relates to its broader receptor binding, including weaker dopamine D2 blockade and stronger serotonin 5-HT2A antagonism, which produces efficacy in patients considered treatment-resistant while causing fewer extrapyramidal symptoms. The tradeoff is agranulocytosis risk, which is why every prescription runs through a mandatory monitoring program rather than routine dispensing.
Administration and timing
Clozapine is started at a low dose and titrated slowly upward over days to weeks to reduce the risk of seizures, orthostatic hypotension, and sedation. Doses are typically split, with a larger portion given at night because of sedation.
Dispensing is tied directly to the patient's most recent absolute neutrophil count through a REMS (Risk Evaluation and Mitigation Strategy) program in the US, or equivalent monitoring schemes elsewhere. The pharmacy will not release the drug without a documented, acceptable count, and nurses should never administer a dose without confirming that the required blood work has actually been done and reviewed.
Monitoring parameters
The absolute neutrophil count (ANC) is checked weekly for the first six months, then every two weeks for the next six months, then monthly if stable, though exact intervals depend on local protocol. An ANC below the threshold set by the monitoring program (commonly below 1500/microL, or a lower threshold for patients with benign ethnic neutropenia) means the drug is withheld.
Monitor weight, fasting glucose, and lipids regularly because of metabolic syndrome risk. Check blood pressure lying and standing during titration for orthostatic hypotension, and monitor for constipation at every contact, since clozapine-induced bowel hypomotility can progress to ileus and is a serious, sometimes fatal, complication.
Adverse effects to report
Fever, sore throat, mouth ulcers, or any sign of infection must be reported and treated as a possible agranulocytosis presentation, not a routine cold. The drug is held and an ANC is drawn immediately.
Report new-onset seizure activity, marked sedation, drooling, tachycardia, or signs of myocarditis such as chest pain, unexplained fatigue, or fever in the first weeks of treatment. Severe constipation, abdominal distension, or absent bowel sounds should be treated as a potential bowel obstruction and escalated promptly, since clozapine-related ileus can be fatal if missed.
Contraindications and cautions
Clozapine is contraindicated in patients with a history of clozapine-induced agranulocytosis, uncontrolled epilepsy, severe CNS depression or coma, and paralytic ileus. Use with caution in patients with cardiac disease, given the myocarditis and cardiomyopathy risk, and in those with a seizure disorder, since clozapine lowers seizure threshold in a dose-dependent way.
Combining clozapine with other drugs that suppress bone marrow, such as carbamazepine, increases agranulocytosis risk and is generally avoided. Caution is also needed with other CNS depressants and with benzodiazepines, since the combination has been linked to respiratory depression and cardiac arrest in some cases.
Teaching points the exam tests
Patients must understand that missing scheduled blood tests means missing doses, since the pharmacy will not dispense without a current, acceptable ANC. This is a frequent point of confusion and non-adherence that exams and real practice both test heavily.
Tell the patient to seek care immediately for fever, sore throat, or flu-like symptoms rather than waiting it out, and to report severe constipation early rather than treating it as minor. Warn about drooling, sedation, and orthostatic dizziness, especially during dose titration, and stress that clozapine must never be restarted without prescriber guidance after a gap of missed doses, since re-titration from scratch is often required to avoid adverse effects.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our mental health practice questions are the closest set to what this page covers.
Common questions
What blood test is required before every clozapine dose?
An absolute neutrophil count (ANC) must be checked and meet the required threshold before the pharmacy dispenses each supply. This monitors for agranulocytosis, the drug's most serious adverse effect.
What should a nurse do if a patient on clozapine develops a fever?
Hold the dose, notify the prescriber, and arrange an urgent ANC. Fever or sore throat in a patient on clozapine is treated as a possible sign of agranulocytosis until proven otherwise.
Why is clozapine used only after other antipsychotics fail?
Its agranulocytosis risk and demanding monitoring requirements mean it is reserved for treatment-resistant schizophrenia, generally after at least two other antipsychotics have failed. The benefit in resistant cases outweighs the risk only when other options have not worked.
What GI complication is unique to clozapine?
Clozapine can cause severe constipation progressing to bowel hypomotility or ileus, which can be fatal if missed. Bowel function should be assessed at every contact, not just when the patient reports a problem.
Can clozapine cause seizures?
Yes, it lowers the seizure threshold in a dose-dependent manner, so risk increases at higher doses. Report any new seizure activity immediately and expect closer monitoring during dose titration.
More on mental health